BI-6C9
CAS No. 791835-21-7
BI-6C9( —— )
Catalog No. M20490 CAS No. 791835-21-7
BI-6C9 is an inhibitor of tBid (Kd = 20 μM).BI-6c9 prevented MOMP and mitochondrial fission and protected the cells from cell death.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 145 | In Stock |
|
| 2MG | 83 | In Stock |
|
| 5MG | 140 | In Stock |
|
| 10MG | 211 | In Stock |
|
| 25MG | 376 | In Stock |
|
| 50MG | 546 | In Stock |
|
| 100MG | 765 | In Stock |
|
| 200MG | 1014 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBI-6C9
-
NoteResearch use only, not for human use.
-
Brief DescriptionBI-6C9 is an inhibitor of tBid (Kd = 20 μM).BI-6c9 prevented MOMP and mitochondrial fission and protected the cells from cell death.
-
DescriptionBI-6C9 is an inhibitor of tBid (Kd = 20 μM).BI-6c9 prevented MOMP and mitochondrial fission and protected the cells from cell death.
-
In VitroCell Viability Assay Cell Line:HT-22 cells Concentration:10 μM Incubation Time:18 hours Result:Attenuated Glutamate-induced cell death.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptortBid
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number791835-21-7
-
Formula Weight471.59
-
Molecular FormulaC23H25N3O4S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (530.12 mM)
-
SMILESCOc1ccc(cc1)S(=O)(=O)NCCCC(=O)Nc1ccc(Sc2ccc(N)cc2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
7-(4-hydroxy-3-metho...
7-(4-hydroxy-3-methoxyphenyl)-1-phenylhept-4-en-3-one (DPHB) is a natural product for research related to life sciences.
-
Angiogenin (108-122)...
Angiogenin (108-122) TFA is an angiogenin peptide.Angiogenin (108-122) acts as a therapeutic agent for the prophylaxis and/or treatment of cancer, an infectious disease, a fibrotic disease, an inflammatory disease, a neurodegenerative disease, an autoimmune disease, or a heart and vascular disease.
-
pep2-AVKI
Inhibitor peptide that selectively disrupts binding of the AMPA receptor subunit GluA2 (at the C-terminal PDZ site) to protein interacting with C kinase (PICK1). Does not affect binding of GluA2 to GRIP or ABP and does not increase AMPA current amplitude or affect long term depression (LTD).
Cart
sales@molnova.com